Active ingredientLiraglutideCat. No. P-L073-001CAS 204656-20-2Family · Pharmaceutical analytical standards
Liraglutide
An analogue of GLP-1, the gut hormone that stimulates insulin after meals, approved for type 2 diabetes in Europe in 2009 and in the United States in 2010; at a higher dose, since 2014, it is also used for weight management. This family brings together the active ingredient.
Did you know?It is 97% identical to human GLP-1: a fatty acid chain added to the molecule makes it bind to blood proteins, so it stays active for about half a day instead of a few minutes.
Go to the active ingredient →Active ingredientLiraglutideCat. No. P-L073-001CAS 204656-20-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.